FRONTIER INVESTMENT MGMT CO - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 59 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRONTIER INVESTMENT MGMT CO ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$31,000
-42.6%
23,8500.0%0.00%
-42.9%
Q1 2016$54,000
-34.9%
23,8500.0%0.01%
-46.2%
Q4 2015$83,000
+20.3%
23,8500.0%0.01%
+8.3%
Q3 2015$69,000
+21.1%
23,8500.0%0.01%
+71.4%
Q2 2015$57,0000.0%23,8500.0%0.01%
-12.5%
Q1 2015$57,000
-30.5%
23,8500.0%0.01%
-42.9%
Q4 2014$82,000
-6.8%
23,850
-4.6%
0.01%0.0%
Q3 2014$88,00025,0000.01%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,595,484$10,564,0009.31%
Cypress Capital Management LLC (WY) 108,400$441,0000.50%
Noven Financial Group, Inc. 158,059$643,0000.37%
Transform Wealth, LLC 205,481$836,0000.15%
GHP Investment Advisors, Inc. 100,000$407,0000.06%
Pratt Collard Advisory Partners LLC 15,600$63,0000.05%
JANICZEK WEALTH MANAGEMENT, LLC 16,719$68,0000.04%
Virtu Financial LLC 92,344$376,0000.02%
JFS WEALTH ADVISORS, LLC 18,150$74,0000.02%
CONDOR CAPITAL MANAGEMENT 21,400$87,0000.02%
View complete list of AMPIO PHARMACEUTICALS INC shareholders